Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium - PubMed (original) (raw)
Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium
Loris Y Hwang et al. J Reprod Immunol. 2011 Jan.
Abstract
Young women aged 15-24 years have the highest rates of sexually transmitted infections (STIs). The vulnerability of adolescents is often attributed to risky sexual behaviors, whereas biological factors affecting mucosal immunity are poorly understood. The objective of this cross-sectional study was to examine associations between the type of cervical epithelium and protein levels of 11 cervicovaginal cytokines and chemokines in non-pregnant healthy young women. Cervical epithelial types were viewed on colpophotography and measured quantitatively using computerized planimetry. We selected 16 women with immature epithelium (predominantly columnar and early/mid squamous metaplasia), and 16 women with mature epithelium (predominantly squamous epithelium). Cytokine levels were measured in cervicovaginal lavage samples by MILLIPLEX™ MAP Human Cytokine/Chemokine multiplex immunoassay. Bivariate Box-Cox regression models compared cytokine levels between immature and mature groups. Multivariate Box-Cox models adjusted separately for age, years since menarche, days since last menses, years of sexual activity, number of lifetime sexual partners, HPV infection, hormonal contraceptive use, smoking, bacterial vaginosis by Nugent's criteria, and polymorphonuclear cells on wet prep. The mean age was 19.2 years. Women with immature epithelium demonstrated significantly higher levels of IL-1α, IL-1β, IL-6, IL-8, MIP-1α, RANTES, TNFα, IL-10, IL-12 and IFNγ (each p<0.01), compared to women with mature epithelium. Results remained highly significant in the multivariate models. Cytokine profiles in the healthy state may foreshadow differential responses to pathogens. Cervical epithelial type should be measured in clinical studies involving cervicovaginal immune markers.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Figures
Figure 1
Quantitative measurements of the cervix performed by colpophotography and computerized planimetry. Cervical immaturity was defined as areas of columnar and early-mid squamous metaplasia and calculated as a percentage of the total cervical face. (A) Example of cervical immaturity measured as 67% of the total cervical face. (B) Example of cervical immaturity measured as <5% of the total cervical face.
Figure 1
Quantitative measurements of the cervix performed by colpophotography and computerized planimetry. Cervical immaturity was defined as areas of columnar and early-mid squamous metaplasia and calculated as a percentage of the total cervical face. (A) Example of cervical immaturity measured as 67% of the total cervical face. (B) Example of cervical immaturity measured as <5% of the total cervical face.
Similar articles
- Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia.
Moscicki AB, Winkler B, Irwin CE Jr, Schachter J. Moscicki AB, et al. J Pediatr. 1989 Sep;115(3):487-93. doi: 10.1016/s0022-3476(89)80863-7. J Pediatr. 1989. PMID: 2769512 - Cervicovaginal cytokines, sialidase activity and bacterial load in reproductive-aged women with intermediate vaginal flora.
Santos-Greatti MMV, da Silva MG, Ferreira CST, Marconi C. Santos-Greatti MMV, et al. J Reprod Immunol. 2016 Nov;118:36-41. doi: 10.1016/j.jri.2016.08.005. Epub 2016 Aug 17. J Reprod Immunol. 2016. PMID: 27620141 - Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.
Hwang LY, Scott ME, Ma Y, Moscicki AB. Hwang LY, et al. Am J Reprod Immunol. 2015 Sep;74(3):228-36. doi: 10.1111/aji.12401. Epub 2015 May 20. Am J Reprod Immunol. 2015. PMID: 25989718 Free PMC article. - Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.
Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JA. Masson L, et al. Sex Transm Infect. 2016 May;92(3):186-93. doi: 10.1136/sextrans-2015-052072. Epub 2015 Oct 28. Sex Transm Infect. 2016. PMID: 26511781 Free PMC article. - Factors that influence the rate of epithelial maturation in the cervix in healthy young women.
Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, Jonte J, Godwin de Medina C, Moscicki AB. Hwang LY, et al. J Adolesc Health. 2009 Feb;44(2):103-110. doi: 10.1016/j.jadohealth.2008.10.006. J Adolesc Health. 2009. PMID: 19167657 Free PMC article.
Cited by
- Asymptomatic infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women in low- and middle-income countries: A systematic review and meta-analysis.
Fortas C, Delarocque-Astagneau E, Randremanana RV, Crucitti T, Huynh BT. Fortas C, et al. PLOS Glob Public Health. 2024 May 23;4(5):e0003226. doi: 10.1371/journal.pgph.0003226. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38781286 Free PMC article. - Cervical Health in Systemic Lupus Erythematosus.
Dhar JP, Walline H, Mor G, Fathallah L, Szpunar S, Saravolatz L, Carey T. Dhar JP, et al. Womens Health Rep (New Rochelle). 2023 Jul 12;4(1):328-337. doi: 10.1089/whr.2023.0023. eCollection 2023. Womens Health Rep (New Rochelle). 2023. PMID: 37476603 Free PMC article. - Non-Lactobacillus-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition.
Wang Y, Noël-Romas L, Perner M, Knodel S, Molatlhegi R, Hoger S, Birse K, Zuend CF, McKinnon LR, Burgener AD. Wang Y, et al. Clin Infect Dis. 2023 Apr 17;76(8):1372-1381. doi: 10.1093/cid/ciac938. Clin Infect Dis. 2023. PMID: 36504254 Free PMC article. Clinical Trial. - Starting to have sexual intercourse is associated with increases in cervicovaginal immune mediators in young women: a prospective study and meta-analysis.
Hughes SM, Levy CN, Calienes FL, Martinez KA, Selke S, Tapia K, Chohan BH, Oluoch L, Kiptinness C, Wald A, Ghosh M, Hardy L, Ngure K, Mugo NR, Hladik F, Roxby AC. Hughes SM, et al. Elife. 2022 Oct 25;11:e78565. doi: 10.7554/eLife.78565. Elife. 2022. PMID: 36281966 Free PMC article. - Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.
Hughes SM, Levy CN, Katz R, Lokken EM, Anahtar MN, Hall MB, Bradley F, Castle PE, Cortez V, Doncel GF, Fichorova R, Fidel PL Jr, Fowke KR, Francis SC, Ghosh M, Hwang LY, Jais M, Jespers V, Joag V, Kaul R, Kyongo J, Lahey T, Li H, Makinde J, McKinnon LR, Moscicki AB, Novak RM, Patel MV, Sriprasert I, Thurman AR, Yegorov S, Mugo NR, Roxby AC, Micks E, Hladik F; Consortium for Assessing Immunity Across the Menstrual Cycle. Hughes SM, et al. BMC Med. 2022 Oct 5;20(1):353. doi: 10.1186/s12916-022-02532-9. BMC Med. 2022. PMID: 36195867 Free PMC article.
References
- Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Homes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22. - PubMed
- Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B (Methodological) 1964;26:211–46.
- Brunham RC, Peeling RW. Chlamydia trachomatis antigens: Role in immunity and pathogenesis. Infect Agents Dis. 1994;3:218–33. - PubMed
- Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2008. U.S. Department of Health and Human Services; Atlanta, Georgia: 2009.
- Fahey JV, Schaefer TM, Channon JY, Wira CR. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod. 2005;20:1439–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R37CA51323-17/CA/NCI NIH HHS/United States
- K23 AI076670/AI/NIAID NIH HHS/United States
- R37 CA051323-20/CA/NCI NIH HHS/United States
- R37 CA051323-17/CA/NCI NIH HHS/United States
- K23AI076670/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- T32HD044331/HD/NICHD NIH HHS/United States
- UL1 RR024131-02/RR/NCRR NIH HHS/United States
- K23 AI076670-03/AI/NIAID NIH HHS/United States
- T32 HD044331/HD/NICHD NIH HHS/United States
- T32 HD044331-04/HD/NICHD NIH HHS/United States
- R37 CA051323/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous